光學成像的全球市場 - 預測(2022年～2027年)

全球光學成像的市場規模在預測期間內預計將以12.14％的年複合成長率增長，從2020年的18億800萬美元，到2027年達到40億3,200萬美元。

本報告提供全球光學成像市場調查，提供市場概要，市場規模和預測，趨勢，促進因素·阻礙因素，各技術·各用途·各地區的分析，及競爭情形等資訊。

目錄

第1章 簡介

• 市場概要
• COVID-19情勢
• 市場定義
• 市場區隔

第2章 調查手法

• 調查資料
• 前提條件

第3章 摘要整理

• 調查的重點

第4章 市場動態

• 推動市場要素
• 阻礙市場要素
• 波特的五力分析
  • 供給企業談判力
  • 買方議價能力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 產業競爭企業間的敵對關係
• 產業價值鏈分析

第5章 光學成像市場:各技術

• 簡介
• 內視鏡檢驗
• 光學同調斷層掃瞄(OCT)
• 光聲成像
• Raman光譜學
• 超高解析度顯微鏡
• 擴散光斷層掃描(DOT)

第6章 光學成像市場:各用途

• 簡介
• 眼科
• 腫瘤學
• 牙科
• 皮膚科
• 神經學
• 其他

第7章 光學成像市場:各地區

• 簡介
• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 南美
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他
• 中東·非洲
  • 沙烏地阿拉伯
  • 以色列
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 日本
  • 韓國
  • 印度
  • 印尼
  • 台灣
  • 其他

第8章 競爭環境與分析

• 主要企業策略分析
• 新興企業與市場的有利性
• 合併，收購，契約，及合作
• 供應商的競爭力矩陣

第9章 企業簡介

• ZEISS Group
• Leica Microsystems
• Topcon Corporation
• Heidelberg Engineering GmbH
• Santec Corporation
• Luneau Technology USA
• Headwall Photonics
• Koninklijke Philips N.V.
• NIDEK CO., LTD.

The optical imaging market is projected to grow at a CAGR of 12.14% during the forecast period to reach US$4.032 billion by 2027, from US$1.808 billion in 2020.

Optical imaging is a technique that makes use of light to interrogate cellular and molecular functions in the human body, plant, and animal tissues. The information is deduced from tissue composition and biomolecular processes and generates images using photons of light from ultraviolet to near-infrared. Techniques namely, bioluminescence, fluorescence, diffuse optical tomography, diffuse optical spectroscopy, confocal microscopy, and multiphoton images, among others are various techniques of optical imaging. Optical Imaging is primarily used by researchers, bio-technicians, bio pharmacists to study small-animal models, and clinical applications for example detection of cancer, and lymphoma, the study of gynaecologic malignancies, vivo imaging, research on DNA, neonatal and adult brain imaging and other applications. Optimal Imaging reduces a patient's exposure to harmful radiation with the help of non-ionizing radiation. Optical Imaging is widely used in biomedical research and medical care.

An increase in biomedical, biopharmaceutical and medical research coupled with an increase in chronic diseases are expected to boost the market for Optical Imaging Market.

Optical imaging is an essential technique that provides useful information to researchers, pharmacists, and biotechnicians for studying complex human, animal, and plant models. Research in biomedical, biopharmaceutical, and medical care is contributing to the growth of the optical imaging market. Optical imaging is increasingly used in eye diseases. The National Institute for Occupational Safety and Health (NIOSH) reports that every day about 2000 US workers suffer from job-related eye injuries which require medical treatment. Novel optical imaging for accurate glaucoma screening is used for early diagnosis and treatment which can slow down or stop the progression to blindness. Vivo imaging, particularly whole-body Vivo imaging enables the study of animal models of human diseases that reduces the rate of experimentation on animals and provide essential information in research studies. Other applications of Vivo imaging can be seen in bioluminescence is used in microbiology and fluorescence methods in vivo imaging are commonly used in clinical research. Pharmacological studies use fluorescence molecular imaging to monitor therapy in the murine models of Alzheimer's disease.

New developments in optical imaging techniques for instance CT (Computed Tomography), MRI (Magnetic Resonance Imaging), and PET-CT (Position Emission Tomography - Computed Tomography) are widely applied in medical imaging techniques. Recent medical optimal imaging that is developed by biomedical research institutions and the community can now measure quantitatively endogenous and exogenous disease markers and spatial dimensions that can guide the clinician in deducing conclusions and arriving at decisions. 3D optical imaging and 3D display have been researched by researchers with their applications in medicine, robotics, security, detection, visualization, and display abilities. For example, 3D medical imaging is a new technology that can improve disease prevention, diagnosis, and treatment in a clinic and operating room. Optical imaging through imaging probes by the use of bioluminescence, chemiluminescence, afterglow imaging, and NIR-II probes having macro-mesoscopic regimes are new advances to study deep tissue imaging.

However, low penetration of optimal imaging, absorption and scattering issues, lacking clinical instrumentation and expertise are the reasons that can hinder the growth of the optical imaging market.

Key Development

Precision Optics, a leading designer and manufacturer of advanced optical instruments for medical and defense industries, acquired Lighthouse Imaging LLC which is a private equity company located in Windham, Maine, in October 2021. The acquisition strengthened the growth of both companies in the market.

Ansys, an engineering simulation software company acquires optical system simulation software company Zemax in August 2021. The acquisition was to provide end-to-end solutions for optics and photonics products in healthcare, autonomy, consumer electronics, and IoT. Additionally, Ansys provided solutions for simulating the behavior of light in complex products that included microscale, human visual perception, imaging of the physical world, and creation of optimal designs by streamlining workflow and communication among photonics.

Leica Microsystems acquired Aivia from SVision LLC which is a privately held company and leading AI-enabled 3D microscopy, image visualization, and analysis software solutions company, in March 2021. The acquisition expanded Leica Microsystem's innovation portfolio of Opto-digital solutions with the addition of AI-based imaging and analysis technologies.

Luneau Technology Group, a pioneer in optical technologies, merged with Optovue Inc, in September 2021. The merger expanded the comprehensive portfolio of health solutions to both the eye-care providers and also expanded their market base in the medical eye-care market.

During the forecast period, North America is expected to hold a high share of the optical imaging market

North America captures a high market share in the optical imaging market due to an increase in research and technological advancements, the surge in eye and brain diseases, cancer, and other diseases, and the presence of optical imaging companies such as Leica Microsystems, Carl Zeiss Meditec, Heidelberg Engineering Inc, Bruker Corporation and others have contributed to the growth of optical imaging market. As per the CDC ( Centres for Disease Control and Prevention) approximately 12 million people of 40 years and above suffer from vision impairment, including 1 million blind, 3 million facing vision impairment after correction, and 8 million people untreated in the United States. Major eye diseases include Glaucoma, Diabetic Retinopathy, Cataracts, and Refractive Error. Brain Diseases mainly Alzheimer, Brain Tumour, Dementia, and Parkinson's Disease are resulting in deaths among people in the United States. Further, MRI Scanning is a technique used to detect images from the brain and deduce results. Cancer is the common reason for deaths in the US particularly brain cancer prevalent among men and women diagnosed with breast cancer. As per National Cancer Institute, estimated cases of cancer come from the US. Positron Emission Tomography and Computed Tomography (PET-CT) Scans aid in detecting cancer stages by describing the location of cancer, its spread, and changing function in the body. Further, 3D optical imaging, ultra-sonic sound-based optical imaging, and AI-based optical imaging are emerging technologies boosting the demand for the optical imaging market in the USA.

COVID-19 Insights

COVID-19 had a significant impact on the optical imaging market as the pandemic increased the demand for optical imaging to detect COVID-19 mutations. Optimal Imaging spectroscopy was used for primary screening of SARS-CoV-2 to identify the infection in patients, patients diagnosed with covid and asymptomatic individuals. However, the supply chain was restrained by physical restrictions nationwide leading to a shortage of optimal imaging devices specifically in developing countries.

Market Market Segmentation:

By Technique

Endoscopy

Optical Coherence Tomography (OCT)

Photoacoustic Imaging

Raman Spectroscopy

Super-resolution Microscopy

Diffuse Optical Tomography (DOT)

By Application

Ophthalmology

Oncology

Dentistry

Dermatology

Neurology

Others

By Geography

North America

USA

Canada

Mexico

South America

Brazil

Argentina

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Others

The Middle East and Africa

Saudi Arabia

Israel

UAE

Others

Asia Pacific

China

Japan

South Korea

India

Indonesia

Taiwan

Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. COVID-19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. OPTICAL IMAGING MARKET BY TECHNIQUE

• 5.1. Introduction
• 5.2. Endoscopy
• 5.3. Optical Coherence Tomography (OCT)
• 5.4. Photoacoustic Imaging
• 5.5. Raman Spectroscopy
• 5.6. Super-resolution Microscopy
• 5.7. Diffuse Optical Tomography (DOT)

6. OPTICAL IMAGING MARKET BY APPLICATIONS

• 6.1. Introduction
• 6.2. Ophthalmology
• 6.3. Oncology
• 6.4. Dentistry
• 6.5. Dermatology
• 6.6. Neurology
• 6.7. Others

7. OPTICAL IMAGING MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. United States
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Italy
  • 7.4.5. Spain
  • 7.4.6. Others
• 7.5. The Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. Israel
  • 7.5.3. UAE
  • 7.5.4. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. Japan
  • 7.6.3. South Korea
  • 7.6.4. India
  • 7.6.5. Indonesia
  • 7.6.6. Taiwan
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrative
• 8.3. Mergers, Acquisition, Agreements, and Collaborations
• 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

• 9.1. ZEISS Group
• 9.2. Leica Microsystems
• 9.3. Topcon Corporation
• 9.4. Heidelberg Engineering GmbH
• 9.5. Santec Corporation
• 9.6. Luneau Technology USA
• 9.7. Headwall Photonics
• 9.8. Koninklijke Philips N.V.
• 9.9. NIDEK CO., LTD.